Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Glaucoma
Interventions
DRUG

Bimatoprost 0.03%, Latanoprost

Trial Locations (1)

15213

Dr. Noecker, Pittsburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Innovative Medical

INDUSTRY